News and views
Our magazine
Insights gives you all the news from the labs, hot topics, health tips and personal stories. Available as a free monthly email or twice-yearly magazine.
Sign up for more news and viewsSeparating fact from fiction: Revealing the truth behind common prostate cancer myths.
There are so many myths out there about prostate cancer and lots of misunderstanding about who is at risk, how to be tested and when to have treatment. Our Specialist Nurse Meg lays the facts on the line.
Enzalutamide has similar benefit to chemo when taken with hormone therapy
For the third time in four years, researchers have found a new treatment option to combine with hormone therapy and improve life expectancy for men with advanced prostate cancer.
New guidelines prompt doctors to offer active surveillance for low risk cancers
We publish new best practice guidelines on active surveillance, as NICE advise it should be offered to men with low risk localised prostate cancer.
Focal therapy is put to the test in new trial
Focal therapy causes fewer side effects when treating localised prostate cancer, so we’re funding a new trial to see if it’s possible to compare it against surgery and radiotherapy.
The Manual: Coping with the emotional fallout from prostate cancer
Health psychologist Dr Emily Robson answers some of your questions and concerns about coping with the emotional fallout from prostate cancer.
LAPCD study reveals lack of support for sexual side effects of prostate cancer treatment
Over 80 per cent of men living between 18 and 42 months after a diagnosis of prostate cancer struggle with poor sexual function, yet fewer than half of these men are offered any support to cope with it.
Latest round of Research Innovation Awards brings our total investment to £50 million
A cancer-killing virus is among eight new research projects that we're funding this year, pushing our total spend on research above £50 million over the last 25 years. We take a closer look at each project and how they build on the work of previous years, getting us closer and closer to taming prostate cancer.
NHS Long Term Plan verdict: a basis for saving more lives but limited on treatments and staffing
BLOG: This week, the Government unveiled its new 10-year plan for the NHS in England. We scrutinised all 136 pages of it to find out what impacts it could have for men being treated or diagnosed for prostate cancer, and how it could help – or hinder – our own plans.
Da Vinci's arrival in Belfast offers robotic prostatectomy to men in Northern Ireland for first time
Belfast City Hospital's £1.5 million robot is set to operate on up to 100 men a year, ending years of men having to travel to England for the procedure and no prostate surgery at all in North Ireland since 2016. We get the reaction from two of our volunteers who have helped us campaign for this welcome breakthrough.
Wrexham nurse wins People’s Choice Award for outstanding commitment to prostate cancer patients
Voted for by her colleagues, patients and their families, Sandie Jones scoops our inaugural award for her extraordinary 20-year career caring for men – from biopsy to post-treatment support. We spoke to her and one of her grateful patients, and find out why we're campaigning for more nurses like Sandie across the UK.